Table 2.

Results of a complete blood count among the patient cohort at baseline and at 20–24 weeks after the initiation of MZR pulse therapy

Laboratory blood tests	Baseline	At weeks 20–24	P
WBC (/µl)	7410 ± 2100	7000 ± 1510	NS
Lymphocyte (/µl)	2050 ± 1690	1750 ± 1110	NS
Neutrocyte (/µl)	5030 ± 1870	4470 ± 940	NS
Hemoglobin (g/dl)	12.7 ± 1.1	12.6 ± 1.5	NS
Platelet count (×104/µl)	32.0 ± 8.0	33.3 ± 9.9	NS

Values are given as the mean ± standard deviation of white blood cell (WBC), lymphocyte, neutrocyte, hemoglobin, and platelet counts before (baseline) and 20–24 weeks after the initiation of MZR pulse therapy

NS not significant